ReBOSSIS 0.2g
ReBOSSIS 0.2g (ORB-0302C) is a synthetic bone graft (FDA Class II; FDA product code MQV, Filler, Bone Void, Calcium Compound) made by Orthorebirth Co., Ltd., listed in FDA GUDID since 1 Sep 2024 (UDI-DI 04573190050309), registry data as of 23 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number04573190050309 | Date1 Sep 2024 | StatusListed |
Official records
- AccessGUDID record 04573190050309
From the FDA record
- Device description
- ReBOSSIS is a cotton-like synthetic, resorbable bone void filler. It is composite material consisting of beta-tricalcium phosphate, siloxane-containing vaterite (a form of calcium carbonate), and poly(L-lactide co glycolide). The electrospinning process used in manufacturing ReBOSSIS results in a cotton-like physical form. Due to its physical form, ReBOSSIS is flexible and can easily fill defects in appropriate amounts.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied sterile
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade name
- ReBOSSIS
- Generic name
- Synthetic bone graft
- Model / Ref / Catalog
- 0.2g, ORB-0302C
- Primary DI / UDI-DI
- 04573190050309
- FDA product code
- MQV
- GMDN term
- Synthetic bone graft
- Device class
- Class II
- Regulation number
- 888.3045
- GUDID distribution status
- In Commercial Distribution
- Size
- Total Volume — 2 Milliliter
Similar devices in this category
Other devices filed under Synthetic bone graft.